<DrugInformationSummary id="CDR0000539385"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Lapatinib ditosylate works by blocking the activity of HER2, a protein found in high levels on some cancer cells and causes them to grow. This may slow or stop the growth of cells that have a lot of HER2.  Lapatinib ditosylate is a type of targeted therapy drug called a kinase inhibitor. It is a small-molecule drug (a drug that can enter cells easily).</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/lapatinibditosylate">Lapatinib Ditosylate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000269659">lapatinib ditosylate</TerminologyLink><GlossaryLink ref="CDR0000539453">lapatinib ditosylate</GlossaryLink><USBrandNames><USBrandName>Tykerb</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>luh-PA-tih-nib dy-TOH-sih-layt</TermPronunciation><MediaLink ref="CDR0000718300" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000718301" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eee37f88-ec6a-4c30-b8aa-e2c71f93088c&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Lapatinib Ditosylate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eee37f88-ec6a-4c30-b8aa-e2c71f93088c&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_4">Lapatinib ditosylate is approved to be used with other   drugs to treat:</Para><ItemizedList Style="bullet" id="_6"><ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000478743" dictionary="Cancer.gov" audience="Patient">advanced</GlossaryTermRef> or has <GlossaryTermRef href="CDR0000046283" dictionary="Cancer.gov" audience="Patient">metastasized</GlossaryTermRef> (spread to other parts of the body). It is used with:<ItemizedList Style="bullet" id="_7"><ListItem><GlossaryTermRef href="CDR0000045565" dictionary="Cancer.gov" audience="Patient">capecitabine</GlossaryTermRef> in women with <GlossaryTermRef href="CDR0000737998" dictionary="Cancer.gov" audience="Patient">HER2 positive</GlossaryTermRef> (HER2+) breast cancer whose disease was treated with an <GlossaryTermRef href="CDR0000044916" dictionary="Cancer.gov" audience="Patient">anthracycline</GlossaryTermRef>, a <GlossaryTermRef href="CDR0000046138" dictionary="Cancer.gov" audience="Patient">taxane</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000045439" dictionary="Cancer.gov" audience="Patient">trastuzumab</GlossaryTermRef></ListItem><ListItem><GlossaryTermRef href="CDR0000045421" dictionary="Cancer.gov" audience="Patient">letrozole</GlossaryTermRef> in <GlossaryTermRef href="CDR0000045269" dictionary="Cancer.gov" audience="Patient">postmenopausal</GlossaryTermRef> women with HER2+  and <GlossaryTermRef href="CDR0000788029" dictionary="Cancer.gov" audience="Patient">hormone receptorâ€“positive</GlossaryTermRef> (HR+) breast cancer who need <GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">hormone therapy</GlossaryTermRef></ListItem></ItemizedList></ListItem></ItemizedList><Para id="_3">Lapatinib ditosylate is also being studied in the treatment of other types of cancer.</Para>                          
 </Section><Section id="_About"><Title>More About Lapatinib Ditosylate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/269659">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.16">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a607055.html">Lapatinib Ditosylate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.17"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.18">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C66878">Find Clinical Trials for Lapatinib Ditosylate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2007-03-16</DateFirstPublished><DateLastModified>2024-12-23</DateLastModified></DrugInformationSummary>
